We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$11.2M
Cap. Flow
+$1.58M
Cap. Flow %
0.64%
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$7.05M
2
AMZN icon
Amazon
AMZN
+$3.89M
3
QURE icon
uniQure
QURE
+$2.86M
4
BNTX icon
BioNTech
BNTX
+$2.81M
5
DXCM icon
DexCom
DXCM
+$2.78M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.6M
2
PG icon
Procter & Gamble
PG
+$3.27M
3
NVO
Novo Nordisk
NVO
+$3.16M
4
CVS icon
CVS Health
CVS
+$3.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.85M

Sector Composition

Rank Sector Weight
1 Technology 35.23%
2 Healthcare 25.2%
3 Consumer Discretionary 20.47%
4 Communication Services 8.05%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KZR
301
DELISTED
Kezar Life Sciences
KZR
$4.89K ﹤0.01%
70
+6
+9% +$445
KLRS
302
Kalaris Therapeutics
KLRS
$93.8M
$4.86K ﹤0.01%
41
+3
+8% +$509
SRRK icon
303
Scholar Rock
SRRK
$6.55B
$4.75K ﹤0.01%
525
+42
+9% +$337
PHAT icon
304
Phathom Pharmaceuticals
PHAT
$742M
$4.75K ﹤0.01%
423
+56
+15% +$577
STRO icon
305
Sutro Biopharma
STRO
$353M
$4.71K ﹤0.01%
58
+9
+18% +$625
ALXO icon
306
ALX Oncology
ALXO
$278M
$4.67K ﹤0.01%
414
+32
+8% +$359
ESPR
307
DELISTED
Esperion Therapeutics
ESPR
$4.67K ﹤0.01%
749
+126
+20% +$901
PSTX
308
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$4.63K ﹤0.01%
874
+70
+9% +$320
ARCT icon
309
Arcturus Therapeutics
ARCT
$216M
$4.56K ﹤0.01%
269
+20
+8% +$349
ATAI icon
310
AtaiBeckley Inc
ATAI
$2.68B
$4.48K ﹤0.01%
1,685
+170
+11% +$516
AVDL
311
DELISTED
Avadel Pharmaceuticals
AVDL
$4.42K ﹤0.01%
618
+66
+12% +$463
NKTR icon
312
Nektar Therapeutics
NKTR
$2.57B
$4.32K ﹤0.01%
127
+10
+9% +$484
EOLS icon
313
Evolus
EOLS
$536M
$4.29K ﹤0.01%
571
+46
+9% +$356
VNDA icon
314
Vanda Pharmaceuticals
VNDA
$314M
$4.25K ﹤0.01%
575
+45
+8% +$438
MGNX icon
315
MacroGenics
MGNX
$256M
$4.19K ﹤0.01%
624
+49
+9% +$269
NGM
316
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.17K ﹤0.01%
830
+78
+10% +$489
HROW icon
317
Harrow
HROW
$1.48B
$4.1K ﹤0.01%
278
+25
+10% +$299
AVIR icon
318
Atea Pharmaceuticals
AVIR
$405M
$4.07K ﹤0.01%
846
+66
+8% +$334
PMVP icon
319
PMV Pharmaceuticals
PMVP
$67.2M
$4.04K ﹤0.01%
464
+37
+9% +$394
XPEV icon
320
XPeng
XPEV
$11.2B
$3.98K ﹤0.01%
400
-4,400
-92% -$39.7K
TARS icon
321
Tarsus Pharmaceuticals
TARS
$3.07B
$3.97K ﹤0.01%
+271
New +$4.48K
INO icon
322
Inovio Pharmaceuticals
INO
$79.6M
$3.96K ﹤0.01%
211
+16
+8% +$363
TERN
323
DELISTED
Terns Pharmaceuticals
TERN
$3.9K ﹤0.01%
383
+30
+8% +$200
CRBU icon
324
Caribou Biosciences
CRBU
$169M
$3.89K ﹤0.01%
620
+50
+9% +$445
ACET icon
325
Adicet Bio
ACET
$77.3M
$3.89K ﹤0.01%
27
+4
+17% +$998
11 12
13
14 15

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
RIA
Recurrent Investment Advisors Houston, Texas $1.66B AUM 38.27% 1-Year Est. Return

China Universal Asset Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
  • China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
  • China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
  • China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
  • China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
  • China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.